Page 44 - ANZCP Gazette-August-Booklet

14. Which of the following congenital heart diseases may not have polycythemia?
a. Pulmonary atresia with intact ventricular septum
b. Single ventricle with pulmonary stenosis
c. Tricuspid atresia with pulmonary stenosis
d. Severe pulmonary stenosis with intact ventricular septum and intra atrial septum
15. Which of the following events is most likely to cause a focal brain damage?
a. Atherosclerotic plaque at aortic cannulation site
b. BP of <15 mmHg for an extended period during CPB
c. Arterial saturation of 90% with circulating Hct of 15%
during CPB
d. Excessive negative pressure during assisted venous
drainage
16. The earliest change after bank storage of whole blood is:
a. Fall in platelet count
b. Steep fall in blood sugar
c. Blood pH falling below 7.25
d. A sharp rise in blood ammonia levels
17. Which of the following statements about ‘heparin resistance’ is false?
a. Is defined as ACT is < 480 sec after 3 mg/kg dose of heparin during cardiac surgery
b. Is seen only if patient is on heparin for a minimum of 7 days
c. Can be seen in patients on IABP
d. Can be due to insufficient antithrombin III
e. Is treated by adding FFP
18. In a membrane oxygenator size of the pores should be less than 1 micron to:
a. Inhibit gas leak
b. Inhibit serum leak
c. Inhibit gas and serum leak
d. Improve oxygenation
e. Improve CO2 removal
19. During ‘trickle flow’, the pump flow is:
a. 5 ml/min
b. 50 ml/min
c. 50 ml/min/m2
d. 500 ml/min
e. 500 ml/min/m2
20. ‘Sieving Coefficient’ for any solute during ultrafiltration, at best, could be:
a. 0.5 b. 1.0 c. 2.0 d. 4.0
Quiz #1 – References
Question: 1
Kurusz, M., & Mills, N. (2000). Management of unusual prob- lems encountered in initiating and maintaining cardiopulmonary bypass. In G. P. Gravlee (Ed.), Cardiopulmonary bypass: princi- ples and practice. (2nd ed., p. 594). Philadelphia, PA: Lippincott Williams & Wilkins.
Question: 2
Galvagno, S. M., Nahmias, J. T., & Young, D. A. (2019). Advanced trauma life support® Update 2019: management and applications for adults and special populations. Anesthesiology clinics, 37(1), 13-32.
Question: 3
Horrow, J., & Fitch, J. (2000). Management of coagulopathy associated with cardiopulmonary bypass. In G. P. Gravlee (Ed.), Cardiopulmonary bypass: principles and practice. (2nd ed., p. 507). Philadelphia, PA: Lippincott Williams & Wilkins.
Question: 4
Kirklin, J. W., & Barratt-Boyes, B. G. (1997). Cardiac Surgery (2nd ed., p. 87). New York: Churchill Livingstone.
Question: 6
Zaidan, J. R. (1995) Initiation and maintenance of cardiopul- monary bypass. In C. T. Mora (Ed.) Cardiopulmonary bypass: principles and techniques of extracorporeal circulation. (p. 270). New York: Springer-Verlag.
Question: 11
Hornick, P., & Taylor, K. M. (2000). Immune and inflammatory responses after cardiopulmonary bypass. In G. P. Gravlee (Ed.), Cardiopulmonary bypass: principles and practice. (2nd ed., p. 307). Philadelphia, PA: Lippincott Williams & Wilkins.
Question: 13
Lich, B. V., & Brown, D. M. (2004). The Manual of Clinical Perfusion (2nd ed., p. 111). Perfusion.Com. Publications
Question: 17
Shore-Lesserson, L., & Gravlee, G. P. (2000). Anticoagulation for cardiopulmonary bypass. In G. P. Gravlee (Ed.), Cardiopul- monary bypass: principles and practice. (2nd ed., pp. 455-8). Philadelphia, PA: Lippincott Williams & Wilkins.
Question: 20
Moore, R. A., & Laub, G. W. (2000). Hemofiltration, dialysis, and blood salvage techniques during cardiopulmonary bypass.
In G. P. Gravlee (Ed.), Cardiopulmonary bypass: principles and practice. (2nd ed., p. 107). Philadelphia, PA: Lippincott Williams & Wilkins.
Answers on page 42
41 SEPTEMBER 2020 | www.anzcp.org